imatinib mesylate has been researched along with Lichen Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuav, R; Goldenberg, G; High, W; Pass, C; Skupsky, H | 1 |
1 other study(ies) available for imatinib mesylate and Lichen Sclerosis
| Article | Year |
|---|---|
Development of lichen sclerosus et atrophicus while receiving a therapeutic dose of imatinib mesylate for chronic myelogenous leukemia.
Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myeloid; Lichen Sclerosus et Atrophicus; Piperazines; Pyrimidines | 2010 |